Transcranial direct current stimul… for Parkinson's (NCT07291687)
Improve walking with transcranial stimulation
- Trial ID
- NCT07291687
- Official Title
- Transcranial Direct Current Stimulation as a Treatment for Motor Function in Participants Living With Progressive Supranuclear Palsy, Corticalbasal Syndrome Degeneration, or Parkinson's Disease
- Goal
- Improve walking with transcranial stimulation
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Baycrest
- Study Type
- INTERVENTIONAL
- Enrollment
- 20 participants
- Conditions
- Progressive Supranuclear Palsy, Cortical Basal Ganglionic Degeneration, Parkinson Disease
- Interventions
- Transcranial direct current stimulation (TDCS), Stimulation Arm
Summary For Families
The trial is testing whether mild electrical brain stimulation can improve walking and other motor problems in people with progressive supranuclear palsy, corticobasal degeneration, or Parkinson's disease. It uses transcranial direct current stimulation, a low-intensity current applied to the scalp that changes cortical excitability to strengthen motor circuits; because it is a non-drug intervention it does not alter how levodopa is metabolized and can be given alongside usual Parkinson's meds. The study is looking for adults with one of those diagnoses who walk daily, either unaided or with a cane or walker, who can communicate in English, and who do not have metal implants in the brain such as shunts.
Locations
- Baycrest Academy of Health Sciences and Geriatric Research, Toronto, Ontario, Canada
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Transcranial direct current stimulation (TDCS). The trial is testing whether mild electrical brain stimulation can improve walking and other motor problems in people with progressive supranuclear palsy, corticobasal degeneration, or Parkinson's disease. It uses transcranial direct current stimulation, a low-intensity current applied to the scalp that changes cortical excitability to strengthen motor circuits; because it is a non-drug intervention it does not alter how levodopa is metabolized and can be given alongside usual Parkinson's meds. The study is looking for adults with one of those diagnoses who walk daily, either unaided or with a cane or walker, who can communicate in English, and who do not have metal implants in the brain such as shunts.
- Who can participate?
- Eligibility criteria vary. Check the full listing on ClinicalTrials.gov for detailed inclusion and exclusion criteria.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 3 years and 1 month.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This is a crossover trial: instead of staying in one group, you move through a sequence of assignments, so you receive the active treatment during at least one period of the study. It also includes a placebo or sham phase, so you would be on that during another period. Ask the coordinator for the exact sequence and how long each phase lasts.